The differences in treating older versus younger CLL patients
Treating CLL with venetoclax
Debate on the best first-line treatment for unmutated CLL: opinions from across the Atlantic
A targeted treatment with anti-CD19 CAR T-cells results in different responses
What leads to shorter progression-free survival in CLL patients?